2022
DOI: 10.36901/psicologia.v12i1.1479
|View full text |Cite
|
Sign up to set email alerts
|

Metilfenidato: Propiedades, aplicaciones y controversias

Abstract: El metilfenidato es un fármaco de primera línea para el tratamiento del Trastorno de Déficit de Atención e Hiperactividad (TDAH), aunque su uso no ese limita a este. Se comercializa desde 1954, habiéndose generado gran cantidad de conocimiento acerca de su funcionamiento y efectividad, así como también controversias acerca de su uso. Se presenta una revisión que incluye todos los aspectos que deben ser conocidos por los profesionales que trabajan con pacientes medicados con este fármaco. Abarcamos los mecanism… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Some studies suggest that the increase in dopamine induced by methylphenidate could have an antioxidant effect since dopamine can scavenge free radicals [45,48]. Other studies indicate that methylphenidate would have protective properties by sequestering toxins and toxic metabolites of dopamine through the redistribution of the vesicular monoamine transporter type 2 (VMAT2) [49][50][51][52]. Alternatively, the beneficial effect of methylphenidate would be exerted by protecting cells against neurotoxic metabolites [53] or by increasing the activity of superoxide dismutase (SOD) and CAT.…”
Section: Discussionmentioning
confidence: 99%
“…Some studies suggest that the increase in dopamine induced by methylphenidate could have an antioxidant effect since dopamine can scavenge free radicals [45,48]. Other studies indicate that methylphenidate would have protective properties by sequestering toxins and toxic metabolites of dopamine through the redistribution of the vesicular monoamine transporter type 2 (VMAT2) [49][50][51][52]. Alternatively, the beneficial effect of methylphenidate would be exerted by protecting cells against neurotoxic metabolites [53] or by increasing the activity of superoxide dismutase (SOD) and CAT.…”
Section: Discussionmentioning
confidence: 99%